Acetylcholine Receptor Antibodies (AChR-Ab)
Pathogenic IgG autoantibodies targeting the alpha-subunit of the nicotinic acetylcholine receptor (AChR) on skeletal muscle endplates.
Standard vs. Optimal Reference Rangesnmol/L
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
<0.4 nmol/L (negative)
General reference distribution across unselected commercial populations.
<0.2 nmol/L
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Binds AChRs, cross-linking and accelerating receptor endocytosis and recruiting terminal complement to destroy post-synaptic junctional folds.
Differential Diagnosis
Elevated Levels (AChR-Ab High)
- •Autoimmune Myasthenia Gravis (ocular and generalized)
- •Thymoma-associated myasthenic syndrome
- •Lambert-Eaton overlap
Low Levels (AChR-Ab Low)
- •Seronegative myasthenia gravis (MuSK / LRP4 positive)
- •Normal neuromuscular transmission
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for AChR-Ab
- Targeted organ system imaging or functional dynamic testing related to neuromuscular junction myasthenia
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Acetylcholine Receptor Antibodies - The New England Journal of Medicine (2021). PMID: 34090124
- [2]AChR-Ab Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Acetylcholine Receptor Antibodies (AChR-Ab) into overall healthspan optimization.